Back

The value of the beta2 adrenergic receptor genotype in the prognostic assessment of heart failure

11 May 2024 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - epidemiology, prognosis, outcome 2 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Assistant Professor Alda Pereira Da Silva Oliveira

Faculty of Medicine University of Lisbon, Lisbon (Portugal)

3 More presentations in this session

Presentation thumbnail
Unlocking survival: assessment of potassium levels in heart failure with quadruple guideline directed medical therapy across all ejection fraction spectrum
Assistant Professor I. Colluoglu (Izmir, TR)
Abstract Slides Video
Presentation thumbnail
Understanding factors associated with left ventricular ejection fraction improvement in heart failure: a single-centre analysis
Doctor C. Miguel Goncalves (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
Predicting mortality with ePM-years Index in patients with heart failure and obstructive chronic coronary syndrome
Doctor A. Kurasz (Bialystok, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - epidemiology, prognosis, outcome 2

The Event

Event poster

Heart Failure 2024

11 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Study of multiple parameters of iron metabolism and their impact in heart failure
thumbnail
Congress Presentation
Genotype-dependent NT-proBNP, cardiac remodeling and pharmacokinetic marker dynamics after acute decompensation in heart failure: insights from the BeLove study
thumbnail
Congress Presentation
Role of beta-3 adrenergic receptor polymorphism TRY64ARG in heart failure.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources